Growth momentum Remedy Analytics appears to be a rapidly growing player in pharmaceutical analytics, evidenced by its presence on the 2020 Inc. 5000 list and a revenue range of 25-50 million, suggesting a scalable platform suitable for expansion into larger payer markets and more extensive pharmacy benefits management contracts.

Acquisition potential The 2021 acquisition by Brown & Brown signals a doorway for cross-sell opportunities with large insurance brokers and brokerage networks, enabling enhanced distribution of PharmaLogic claims analytics and clinical intelligence across broader employer and plan sponsor client bases.

Data & analytics core Remedy’s proprietary PharmaLogic claims analytics platform, combined with clinical, actuarial, and data science talent, points to a strong value proposition for enterprise payers and PBMs seeking to optimize drug spend, population health outcomes, and plan design.

Tech stack leverage Current technologies like OneTrust, Oracle Database, cloud hosting and collaboration tools indicate readiness for data governance, security, and scalable analytics workloads, enabling upsell of compliance-heavy analytics, risk assessment, and reporting features to larger clients.

Market positioning With a mid-market size team and competitive landscape featuring industry giants, Remedy can pursue tiered offerings such as hosted analytics services, RFP-to-implementation support, and added-value consulting to win mid-sized plans and mid-market employer groups seeking cost containment and population health gains.